Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.
More Latest News
June 15, 2018
Changes to a mandatory Continuing Education requirement for pharmacists during the current biennium ending on September 30, 2019 Continue reading
June 8, 2018
The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading